00_MJ_Intro_Budapest16.pptx

Previous Page

Next Page

Page Background

ESTRO

Combined chemo- and radiotherapy

treatment

• Spatial co-operation (e.g. breast carcinoma)

• Independent cell kill (e.g. Hodgkin lymphoma)

• Interaction (e.g. H&N, cervix, NSCLC)

• “diluted” toxicity (e.g. Hodgkin lymphoma)